Stem cell infusion could be lifeline for ICU patients with lung failure
Disease control
Ongoing
This study tests whether a single infusion of mesenchymal stem cells (MSCs) can help treat acute respiratory distress syndrome (ARDS), a severe lung condition common in ICU patients, including those with COVID-19. About 129 adults on ventilators will first receive different doses…
Phase: PHASE1, PHASE2 • Sponsor: Belfast Health and Social Care Trust • Aim: Disease control
Last updated May 06, 2026 16:15 UTC